Featured Research

from universities, journals, and other organizations

Novel cytokine protects mice from colitis

Date:
August 23, 2011
Source:
University of California - San Diego
Summary:
Inflammatory bowel disease, which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed to the disorder. Researchers have discovered that expression of a newly identified human cytokine -- interleukin 37 -- protects mice from colitis.

Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed to the disorder. Ulcerative colitis, or inflammation of the lining of the colon, is one such condition.

Related Articles


The aberrant immune response found in IBD is prompted by different cytokines -- small signaling proteins secreted by various cells, including immune cells -- that activate the immune system, causing chronic inflammation.

Now researchers led by Jesϊs Rivera-Nieves, MD, of the Inflammatory Bowel Disease Center, Division of Gastroenterology at the University of California, San Diego School of Medicine, have discovered that expression of a newly identified human cytokine -- interleukin 37 (IL-37) -- protects mice from colitis. The study is being in Proceedings of the National Academy of Sciences (PNAS).

IL-37 is a member of the IL-1 family and functions as an inhibitor of innate inflammation and immunity. While most molecules in the IL-1 family appear to promote an inflammatory response, IL-37 modulates or downgrades inflammation.

Charles A. Dinarello, MD, from the University of Colorado, recently expressed human IL-37 in lab mice, which do not have an orthologue, or similar molecule, for this particular cytokine. Nonetheless, IL-37 works the same in both mice and humans. The mice were then fed water containing dextran sulfate sodium (DSS), a substance that induces colitis, to see whether IL-37 provided protection from intestinal inflammation.

It did. "While we still don't understand its mechanism of action, our hope is that, in the future, scientists may be able to engineer cells to overproduce IL-37 and use it to treat or control an overactive immune system in humans," said Rivera-Nieves.

That would represent a major advance in treating IBD, particularly for the 30 to 50 percent of IBD patients for whom highly effective biological therapies -- tumor necrosis factor inhibitors -- don't work, or for an even larger percentage of patients whose symptoms eventually return.

Co-authors of the paper are Eoin N. McNamee and Almut Grenz of the Mucosal Inflammation Program, Department of Medicine, Children's Hospital Colorado and the University of Colorado Denver; Joanne C. Masterson, Mucosal Inflammation Program, Department of Medicine, Children's Hospital Colorado and Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Gastrointestinal Eosinophilic Disease Program, Children's Hospital Colorado; Paul Jedlicka and Martine McManus, Department of Pathology, University of Colorado Denver; Colm B. Collins, Mucosal Inflammation Program, Department of Medicine, Children's Hospital Colorado and Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Gastrointestinal Eosinophilic Disease Program, Children's Hospital Colorado; Marcel F. Nold and Claudia Nold-Petry, Division of Infectious Diseases, University of Colorado Denver; Philip Bufler, Children's Hospital, Ludwig-Maximilians University, Munich, Germany and Charles A. Dinarello, Division of Infectious Diseases, University of Colorado Denver.

Funding for this research was provided by the NIH/NIDDK and the Crohn's and Colitis Foundation of America.


Story Source:

The above story is based on materials provided by University of California - San Diego. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. N. McNamee, J. C. Masterson, P. Jedlicka, M. McManus, A. Grenz, C. B. Collins, M. F. Nold, C. Nold-Petry, P. Bufler, C. A. Dinarello, J. Rivera-Nieves. Interleukin 37 expression protects mice from colitis. Proceedings of the National Academy of Sciences, 2011; DOI: 10.1073/pnas.1111982108

Cite This Page:

University of California - San Diego. "Novel cytokine protects mice from colitis." ScienceDaily. ScienceDaily, 23 August 2011. <www.sciencedaily.com/releases/2011/08/110823165348.htm>.
University of California - San Diego. (2011, August 23). Novel cytokine protects mice from colitis. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2011/08/110823165348.htm
University of California - San Diego. "Novel cytokine protects mice from colitis." ScienceDaily. www.sciencedaily.com/releases/2011/08/110823165348.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) — The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) — Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) — Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) — Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins